Eltrombopag for the Treatment of Thrombocytopenia Post-Allogeneic Stem Cell Transplantation.

Biology of Blood and Marrow Transplantation(2019)

引用 38|浏览6
暂无评分
摘要
•Eltrombopag was effective in 62% of cases of primary prolonged thrombocytopenia after hematopoietic stem cell transplantation (SCT).•Eltrombopag was effective in cases of secondary platelet failure after SCT.•Bone marrow megakaryotic reserve did not appear to predict response to eltrombopag.•The need for eltrombopag was a poor prognostic marker.
更多
查看译文
关键词
Eltrombopag,Thrombocytopenia,Graft failure,Allogeneic stem cell transplantation,Engraftment,Platelet recovery
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要